Web2 days ago · TEL AVIV, Israel, April 12, 2024 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced the company will discuss its first quarter 2024 … WebChemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical …
Chemomab Announces Appointment of Mitchell L. Jones, MD, …
WebJun 28, 2024 · Chemomab is a clinical stage biotechnology company focusing on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need. WebChemomab Therapeutics to Discuss Fourth Quarter and Full-Year 2024 Financial Results and Provide a Business Update TEL AVIV, Israel, March 17, 2024 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of innovative … dary lasu genially
Chemomab Therapeutics to Discuss First Quarter 2024 Financial …
WebNov 9, 2024 · The presentation, Treatment with CM-101 Reduced Inflammatory & Fibrotic Biomarkers in Patients with COVID-19-Derived Lung Damage, was discussed by Chemomab co-founder and Chief Scientific Officer Dr. Adi Mor at the Union World Conference on Lung Health 2024. Some of the mechanisms underlying lung … WebChemomab (Nasdaq:CMMB) is a clinical-stage biotechnology company focusing on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need ... WebMar 29, 2024 · Chemomab expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Chemomab's ... daryl armstrong